혈관조영 장비 시장 : 시스템 유형, 검출기 유형, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Angiography Equipment Market is projected to grow by USD 21.92 billion at a CAGR of 6.52% by 2032.

Angiography equipment is central to modern image-guided diagnosis and minimally invasive treatment across cardiology, neurology, oncology, vascular surgery, and interventional radiology. Demand is supported by the global burden of cardiovascular disease, which the World Health Organization identifies as the leading cause of death worldwide, and by rising use of catheter-based procedures that can reduce recovery time and hospital stays compared with open surgery.

The angiography equipment landscape includes fixed angiography systems, mobile C-arms, digital subtraction angiography, flat-panel detectors, contrast delivery systems, image-processing platforms, workflow software, and hybrid operating room configurations. Hospitals and specialty centers are prioritizing systems that improve vascular visualization, lower radiation exposure, integrate with electronic health records, and support high-throughput interventional workflows.

Transformative Shifts in the Angiography Landscape

The angiography equipment landscape is shifting from hardware-centric procurement to platform-based imaging ecosystems. Buyers increasingly evaluate detector quality, dose-management tools, image-guided therapy capabilities, interoperability, cybersecurity, uptime performance, clinical workflow integration, and total cost of ownership rather than equipment price alone.

Clinical practice is also changing. Growth in structural heart interventions, neurovascular thrombectomy, peripheral vascular procedures, and oncology embolization is expanding the role of angiography suites. At the same time, aging infrastructure in mature markets and rapid hospital capacity expansion in emerging economies are creating differentiated replacement and first-time installation opportunities.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding value across angiography workflows by supporting image enhancement, automated vessel segmentation, device navigation, dose optimization, anomaly detection, and procedure planning. In radiology, AI has become one of the most active categories in medical-device software authorizations, reflecting the sector's strong fit for image-based algorithms and workflow automation.

The cumulative impact is operational as well as clinical. AI-enabled angiography systems can help standardize image quality, reduce repeat acquisitions, support faster decision-making, and improve lab utilization. Adoption will depend on regulatory validation, explainability, cybersecurity, clinical evidence, and seamless integration with PACS, hemodynamic monitoring, electronic health records, and hospital information systems.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for angiography equipment as China, India, Japan, South Korea, and Australia invest in tertiary care, catheterization laboratories, stroke centers, oncology services, and advanced diagnostic imaging infrastructure. The region combines large patient pools with expanding insurance coverage, while cost sensitivity continues to support demand for scalable configurations, reliable service models, and systems suited to high procedure volumes.

North America remains a high-value angiography equipment region driven by advanced interventional cardiology, neurovascular programs, hybrid operating rooms, outpatient cardiovascular care, and replacement demand in hospitals. Europe benefits from strong clinical standards, public healthcare procurement, radiation-safety requirements, and EU regulatory harmonization, although budget controls can lengthen purchasing cycles. Latin America is advancing through private hospital investment and cardiovascular care expansion, led by Brazil and Mexico. The Middle East is supported by healthcare modernization, specialist centers, and GCC hospital investment, while Africa shows long-term opportunity as diagnostic imaging capacity, cardiovascular care access, and interventional radiology services expand from a lower base.

Key Group Insights

ASEAN demand is tied to hospital network expansion, medical tourism, and government investment in cardiovascular and stroke care, particularly in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. GCC markets are prioritizing premium imaging, hybrid operating rooms, digital hospitals, and specialist centers as Saudi Arabia, the UAE, Qatar, and neighboring countries implement healthcare diversification strategies and strengthen advanced tertiary care capacity.

The European Union emphasizes safety, interoperability, procurement transparency, cybersecurity, and compliance under the Medical Device Regulation, making clinical evidence and post-market surveillance important differentiators. BRICS countries combine large disease burdens with public-private infrastructure investment, though reimbursement models, localization rules, and local manufacturing policies vary by country. G7 markets lead in advanced procedure adoption, clinical standardization, and replacement-cycle demand, while NATO member states add demand linked to resilient healthcare infrastructure, emergency-care readiness, and modernization of critical medical assets.

Key Country Insights

The United States leads adoption through large hospital systems, outpatient cardiovascular networks, and high volumes of interventional cardiology, electrophysiology, peripheral vascular, and neurovascular care. Canada emphasizes quality, equitable access, and provincial procurement, while Mexico and Brazil combine public-sector demand with private hospital expansion and growing cardiovascular treatment access. In Europe, the United Kingdom, Germany, France, Italy, and Spain focus on catheterization laboratory modernization, radiation dose reduction, workflow efficiency, and efficient use of capital budgets, while Russia's demand is influenced by domestic procurement priorities, healthcare modernization programs, and import constraints.

China and India are major growth engines due to population scale, urban hospital investment, expanding insurance coverage, and rising access to minimally invasive cardiovascular and neurovascular procedures. Japan and South Korea favor technologically advanced angiography systems, high image quality, low-dose imaging, and workflow automation, supported by mature hospital infrastructure and strong clinical specialization. Australia maintains strong demand in tertiary hospitals and regional referral centers, with procurement shaped by clinical evidence, service coverage, operator training, and long-term equipment reliability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize angiography systems that combine high-resolution imaging, low-dose protocols, AI-ready software, advanced visualization, and open connectivity with existing hospital IT infrastructure. Vendors that align product roadmaps with interventional cardiology, neurovascular, oncology, peripheral vascular, trauma, and hybrid operating room workflows are better positioned to capture multi-department budgets.

Commercial strategy should be localized. Mature markets require replacement-cycle intelligence, service excellence, cybersecurity assurance, radiation-safety documentation, and evidence-based value propositions. Emerging markets need flexible financing, user training, uptime guarantees, scalable product tiers, and reliable spare-parts access. Partnerships with hospitals, academic centers, training institutes, and local distributors can accelerate adoption while strengthening clinical validation and after-sales support.

Research Methodology

This executive summary is developed through secondary research, industry benchmarking, regulatory review, and triangulation of public health and medical-technology indicators. Sources considered include government health agencies, international health organizations, medical-device regulatory databases, hospital procurement trends, peer-reviewed clinical literature, health infrastructure indicators, and publicly available industry disclosures.

The methodology emphasizes verified, data-backed insights rather than unsupported assumptions. Market interpretation is based on disease burden, procedure demand, healthcare infrastructure, reimbursement dynamics, regulatory requirements, technology adoption, regional investment patterns, and competitive positioning across angiography equipment, software, services, and image-guided therapy ecosystems.

Conclusion

Angiography equipment is moving from a diagnostic imaging asset to a strategic platform for image-guided care. Adoption is supported by cardiovascular and neurovascular disease burden, rising minimally invasive procedures, aging installed bases, and hospital investment in advanced interventional capacity.

The strongest opportunities will emerge where imaging performance, AI-enabled workflow, radiation safety, interoperability, cybersecurity, and service reliability converge. Organizations that combine clinical evidence with localized execution, training, and lifecycle support will be best positioned to lead the next phase of angiography equipment adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Angiography Equipment Market, by System Type

• 7.1. Biplane
• 7.2. Monoplane

8. Angiography Equipment Market, by Detector Type

• 8.1. Flat Panel
• 8.2. Image Intensifier

9. Angiography Equipment Market, by Application

• 9.1. Cardiology
  • 9.1.1. Coronary
  • 9.1.2. Peripheral
• 9.2. Neurology
  • 9.2.1. Cerebral
  • 9.2.2. Spinal
• 9.3. Radiology
  • 9.3.1. Abdominal
  • 9.3.2. Peripheral

10. Angiography Equipment Market, by End User

• 10.1. Diagnostic Centers
• 10.2. Hospitals
• 10.3. Specialty Clinics

11. Angiography Equipment Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Angiography Equipment Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Angiography Equipment Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Agfa-Gevaert Group
• 15.2. Analogic Corporation
• 15.3. Avonix Imaging, LLC by Nikon Corporation
• 15.4. Barco NV
• 15.5. Canon Medical Systems Corporation
• 15.6. Carestream Health, Inc.
• 15.7. Esaote S.p.A
• 15.8. FUJIFILM Holdings Corporation
• 15.9. GE HealthCare Technologies Inc.
• 15.10. Hologic, Inc.
• 15.11. Konica Minolta, Inc.
• 15.12. Koninklijke Philips N.V.
• 15.13. Medtronic PLC
• 15.14. MinFound Medical Systems Co., Ltd.
• 15.15. Neusoft Corporation
• 15.16. Planmed Oy
• 15.17. Samsung Electronics Co., Ltd
• 15.18. Shanghai United Imaging Healthcare Co., Ltd.
• 15.19. Shenzhen Mindray Bio-Medical Electronics Co Ltd.
• 15.20. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
• 15.21. Shimadzu Corporation
• 15.22. Siemens Healthineers AG
• 15.23. Stryker Corporation
• 15.24. Ziehm Imaging GmbH